Movement Alert｜Liquidia Rises 7.26% in Regular Trading, Company Announces Research Poster Presentation at PHA International Pulmonary Hypertension Conference

Market Focus06-11

On June 11, Liquidia rose 7.26% in regular trading, trading at $69.98/share, with turnover of $54.99 million.

On the news front, Liquidia announced it will present research posters at the PHA International Pulmonary Hypertension Conference and Scientific Sessions, highlighting continued R&D progress in its core pulmonary arterial hypertension (PAH) treatment area. The company focuses on developing inhaled therapies through its proprietary PRINT particle engineering technology platform, with lead product YUTREPIA targeting PAH and PH-ILD indications. The catalyst builds on strong recent momentum, with the stock having surged over 15% in the prior week amid growing market attention to its PAH pipeline.

Within the Pharmacy sector, the overall performance was positive. Among individual stocks, Pfizer up 2.91%, Eli Lilly up 2.26%, Merck up 1.5%, Johnson & Johnson up 0.95%, Zoetis down 0.76%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115461028?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 22:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115461028","market":"us","top_or_hot":-1,"title":"Movement Alert｜Liquidia Rises 7.26% in Regular Trading, Company Announces Research Poster Presentation at PHA International Pulmonary Hypertension Conference","media":"Market Focus","content":"<p><p>On June 11, Liquidia rose 7.26% in regular trading, trading at $69.98/share, with turnover of $54.99 million.</p><p>On the news front, Liquidia announced it will present research posters at the PHA International Pulmonary Hypertension Conference and Scientific Sessions, highlighting continued R&D progress in its core pulmonary arterial hypertension (PAH) treatment area. The company focuses on developing inhaled therapies through its proprietary PRINT particle engineering technology platform, with lead product YUTREPIA targeting PAH and PH-ILD indications. The catalyst builds on strong recent momentum, with the stock having surged over 15% in the prior week amid growing market attention to its PAH pipeline.</p><p>Within the Pharmacy sector, the overall performance was positive. Among individual stocks, Pfizer up 2.91%, Eli Lilly up 2.26%, Merck up 1.5%, Johnson & Johnson up 0.95%, Zoetis down 0.76%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Liquidia Rises 7.26% in Regular Trading, Company Announces Research Poster Presentation at PHA International Pulmonary Hypertension Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Liquidia Rises 7.26% in Regular Trading, Company Announces Research Poster Presentation at PHA International Pulmonary Hypertension Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-11 22:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 11, Liquidia rose 7.26% in regular trading, trading at $69.98/share, with turnover of $54.99 million.</p><p>On the news front, Liquidia announced it will present research posters at the PHA International Pulmonary Hypertension Conference and Scientific Sessions, highlighting continued R&D progress in its core pulmonary arterial hypertension (PAH) treatment area. The company focuses on developing inhaled therapies through its proprietary PRINT particle engineering technology platform, with lead product YUTREPIA targeting PAH and PH-ILD indications. The catalyst builds on strong recent momentum, with the stock having surged over 15% in the prior week amid growing market attention to its PAH pipeline.</p><p>Within the Pharmacy sector, the overall performance was positive. Among individual stocks, Pfizer up 2.91%, Eli Lilly up 2.26%, Merck up 1.5%, Johnson & Johnson up 0.95%, Zoetis down 0.76%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1115461028","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115461028","pubTimestamp":1781189750,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 11, Liquidia rose 7.26% in regular trading, trading at $69.98/share, with turnover of $54.99 million.On the news front, Liquidia announced it will present research posters at the PHA...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"动向提示|Liquidia常规交易涨7.26%，公司宣布在PHA国际肺动脉高压会议上展示研究海报","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"On June 11, Liquidia rose 7.26% in regular trading, trading at $69.98/share, with turnover of $54.99 million.On the news front, Liquidia announced it will present research posters at the PHA International Pulmonary Hypertension Conference and Scientific Sessions, highlighting continued R&D progress in its core pulmonary arterial hypertension (PAH) treatment area. The company focuses on developing inhaled therapies through its proprietary PRINT particle engineering technology platform, with lead product YUTREPIA targeting PAH and PH-ILD indications. The catalyst builds on strong recent momentum, with the stock having surged over 15% in the prior week amid growing market attention to its PAH pipeline.Within the Pharmacy sector, the overall performance was positive. Among individual stocks, Pfizer up 2.91%, Eli Lilly up 2.26%, Merck up 1.5%, Johnson & Johnson up 0.95%, Zoetis down 0.76%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"conferences","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115461028","isCrawlerRequest":true}